How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Vaccine Transport Cooler Market
- By Cooler Type: Passive Coolers, Active Coolers, Hybrid Coolers
- By Insulation Material: Polyurethane Foam, Vacuum Insulation Panels (VIP), Expanded Polystyrene (EPS), Extruded Polystyrene (XPS)
- By Temperature Range: 2°C to 8°C (Refrigerated), -20°C to -10°C (Frozen), Ultra-low Temperature (-70°C and below)
- By End User: Hospitals and Clinics, Pharmaceutical Companies, Government Health Agencies, Cold Chain Logistics Providers, Research Laboratories
- By Capacity: Small Capacity (up to 10 liters), Medium Capacity (10 to 50 liters), Large Capacity (above 50 liters)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Passive Coolers leads By Cooler Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.175 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.183 →
Full report · locked preview
Everything inside the Vaccine Transport Cooler Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Cooler Type 3
Insulation Material 4
Temperature Range 3
End User 5
Capacity 3
Companies profiled
Pelican BioThermal
Cryoport
Thermo Fisher Scientific
BD (Becton
Dickinson and Company)
PHC Corporation (formerly Panasonic Healthcare)
Sonoco ThermoSafe
Va-Q-Tec AG
CITC (Cold Chain Technologies)
Softbox Systems
Cold Chain Technologies
MediCool
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Pelican BioThermal
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cryoport
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →BD (Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Dickinson and Company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →PHC Corporation (formerly Panasonic Healthcare)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Sonoco ThermoSafe
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Va-Q-Tec AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →CITC (Cold Chain Technologies)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Softbox Systems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Cold Chain Technologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →MediCool
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Cryopak
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Polar Tech Industries
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Schoeller Allibert
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →CryoSafe
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,807M by 2033 · 6.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Passive Coolers61.8
- Active Coolers16.5
- Hybrid Coolers21.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,552M → $2,322M · 5.2%
Europe$1,082M → $1,964M · 7.7%
Asia Pacific$987.9M → $1,672M · 6.8%
Latin America$611.6M → $899.6M · 4.9%
Middle East and Africa$470.4M → $746.9M · 5.9%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.492026
6.492027
6.522028
6.532029
6.532030
6.542031
6.562032
6.572033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Pelican BioThermal20.2
- Cryoport20.5
- Thermo Fisher Scientific5.4
- BD (Becton11.0
- Dickinson and Company)10.7
- PHC Corporation (formerly Panasonic Healthcare)4.2
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Cooler Type13.9%
Insulation Material13.0%
Temperature Range28.1%
End User26.2%
Capacity18.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.5
- Europe25.8
- Asia Pacific22.0
- Latin America11.8
- Middle East and Africa9.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Pelican BioThermal | 76 | 89 | 84 | 83 | 77 | 90 | 83 |
| Cryoport | 70 | 71 | 92 | 91 | 88 | 77 | 82 |
| Thermo Fisher Scientific | 75 | 85 | 72 | 71 | 75 | 85 | 77 |
| BD (Becton | 77 | 61 | 65 | 71 | 78 | 63 | 69 |
| Dickinson and Company) | 62 | 63 | 68 | 64 | 71 | 58 | 64 |
| PHC Corporation (formerly Panasonic Healthcare) | 51 | 59 | 46 | 69 | 50 | 64 | 57 |
| Sonoco ThermoSafe | 44 | 49 | 50 | 55 | 54 | 60 | 52 |
| Va-Q-Tec AG | 56 | 44 | 58 | 41 | 60 | 46 | 51 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Pelican BioThermal
- Cryoport
- Thermo Fisher Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Pelican BioThermal | ◐ | ◐ | ✓ | ✓ | ◐ | ◐ |
| Cryoport | ✓ | ✓ | ✓ | ◐ | ◐ | ◐ |
| Thermo Fisher Scientific | ✓ | ✓ | − | ✓ | ✓ | ✓ |
| BD (Becton | ✓ | ◐ | ◐ | ◐ | ✓ | ◐ |
| Dickinson and Company) | − | ✓ | − | ◐ | ◐ | − |
| PHC Corporation (formerly Panasonic Healthcare) | ◐ | ◐ | − | ✓ | − | ◐ |
| Sonoco ThermoSafe | − | − | ◐ | − | − | ◐ |
| Va-Q-Tec AG | ◐ | − | ◐ | − | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Pelican BioThermal83
2Cryoport82
3Thermo Fisher Scientific77
4BD (Becton69
5Dickinson and Company)64
6PHC Corporation (formerly Panasonic Healthcare)57
7Sonoco ThermoSafe52
8Va-Q-Tec AG51
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Pelican BioThermalCryoport
Challenger2
Strong scale, closing on the leaders.
Thermo Fisher ScientificBD (Becton
Contender2
Focused players with pockets of strength.
Dickinson and Company)PHC Corporation (formerly Panasonic Healthcare)
Niche2
Specialists in a single segment or region.
Sonoco ThermoSafeVa-Q-Tec AG
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Cooler Type in North America, then scale across Vaccine Transport Cooler Market — a $413M beachhead inside a $7.61B market.
Beachhead (SOM)$413Mobtainable near-term
Serviceable (SAM)$2.72Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Passive Coolers
Best fit — highest urgency & budget in Cooler Type.
Economic buyer80 fit
Active Coolers
Strong fit — clear ROI and a fast path to value.
End user69 fit
Hybrid Coolers
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Cooler Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Insulation Material & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Temperature Range
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel29%
Digital / self-serve20%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Cooler Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Vaccine Transport Cooler Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified23%
Evaluation13%
Closed-won8%
$10.9KCAC
$43KLTV
3.9:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Vaccine Transport Cooler Market is a resilient opportunity — $4.54B by 2033, compounding at 5.1%.
TAM · 2025$3.05Btoday
TAM · 2033$4.54Bforecast
CAGR5.1%2027–2033
Cumulative$33.8Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.54BTotal addressable market
SAM$1.73BServiceable available market
SOM$305MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →5.1% CAGR
Demand compounds through 2033, outpacing GDP across Cooler Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Cooler Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.54BLarge & growingTAM by 2033 at 5.1% CAGR
$1.73BServiceable nowreachable with today’s model
$305MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.54BBear3.3% CAGR
$4.54BBase5.1% CAGR
$5.81BBull6.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Insulation Material optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Vaccine Transport Cooler Market — a $822M market by 2033. Plan: grow share from 5.9% to 12.0%.
Market size · 2033$822Mtotal addressable
Market CAGR3.6%2027–2033
Target share12.0%from 5.9% today
Revenue ambition$99Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.9% | 12.0% | On track |
| Revenue | $51M | $99M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 32.8% | 44.5% | Ahead |
| Customer retention | 91.5% | 93.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Cooler Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Insulation Material capability
A defensible second engine — invest in Insulation Material to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Cooler Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Insulation Material
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $13M capacity & capability investment
- Greenlight bolt-on M&A in Insulation Material
- Authorise North America expansion plan
- Fund R&D program for Cooler Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAt risk
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Vaccine Transport Cooler Market conversation — a $4.17B market you can size, segment and defend in minutes.
Market size · 2033$4.17Btotal opportunity
Growth5.7%CAGR to 2033
Addressable buyers1,054+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Cooler Type
Goal Grow share in Cooler Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 3 mopayback period
$56K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Pelican BioThermalCryoportThermo Fisher ScientificBD (BectonDickinson and Company)PHC Corporation (formerly Panasonic Healthcare)Sonoco ThermoSafeVa-Q-Tec AG+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Vaccine Transport Cooler Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Vaccine Transport Cooler Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Vaccine Transport Carrier Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVaccine Tracking Software Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportVaccine Temperature Monitoring System Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportVaccine Temperature Data Loggers Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportVaccine Syringes Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportVaccine Storage Refrigerators Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportVaccine Storage & Packaging Market
Market size, share, segmentation and regional forecast.
$596M market · 2025 base year
View reportVaccine Storage Medical Refrigerators Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportVaccines Packaging Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportVaccine Shipping Box Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportVaccine Shippers Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportVaccines For Children (VFC) Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.